Special Interview with Dr. Wafik S. El-Deiry — New insights into the potential role of new technologies in overcoming cancer drug resistance in the future.

On October 23, 2025, the editorial office of Cancer Drug Resistance (CDR) had the honor of interviewing Dr. Wafik S. El-Deiry, a member of the journal’s Editorial Board. In this interview, Dr. El-Deiry shared his profound insights into cancer immunotherapy and targeted therapy, emphasizing the critical role of interdisciplinary collaboration in advancing cancer research. He also discussed the frontiers of oncology, reflected on the significance of the 2025 Nobel Prize awarded to the discoverers of Treg cells for the development of tumor immunology, and offered his perspective on the principles researchers should uphold when applying CRISPR/Cas9 technology in scientific exploration.